DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Markman M, Blessing J, Rubin SC. et al.
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study.
Gynecol Oncol 2006;
101: 436-440
doi:10.1016/j.ygyno.2005.10.036
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.